CC

Checkpoint Capital Portfolio holdings

AUM $215M
1-Year Est. Return 27.24%
This Quarter Est. Return
1 Year Est. Return
+27.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$182M
AUM Growth
-$14.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$13.3M
2
+$9.5M
3
+$8.47M
4
SLNO icon
Soleno Therapeutics
SLNO
+$7.35M
5
RVMD icon
Revolution Medicines
RVMD
+$6.44M

Top Sells

1
+$18.5M
2
+$14.8M
3
+$10.6M
4
PLRX icon
Pliant Therapeutics
PLRX
+$7.05M
5
TRVI icon
Trevi Therapeutics
TRVI
+$4.47M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
1
argenx
ARGX
$50.4B
$68.1M 37.34%
115,000
+22,500
RYTM icon
2
Rhythm Pharmaceuticals
RYTM
$7.56B
$48.1M 26.37%
907,240
+179,258
RVMD icon
3
Revolution Medicines
RVMD
$11B
$13.9M 7.61%
392,011
+182,011
SLNO icon
4
Soleno Therapeutics
SLNO
$3.57B
$12.4M 6.78%
172,902
+102,875
IRON icon
5
Disc Medicine
IRON
$3.22B
$12.1M 6.63%
243,311
+58,311
PTGX icon
6
Protagonist Therapeutics
PTGX
$4.89B
$8.47M 4.65%
+175,184
STOK icon
7
Stoke Therapeutics
STOK
$1.65B
$4.86M 2.67%
730,717
+425,330
SEPN
8
Septerna Inc
SEPN
$918M
$4.78M 2.62%
+824,878
KYMR icon
9
Kymera Therapeutics
KYMR
$4.42B
$3.74M 2.05%
136,605
+59,070
TCRX icon
10
TScan Therapeutics
TCRX
$110M
$2.78M 1.53%
2,017,650
+261,663
CDTX icon
11
Cidara Therapeutics
CDTX
$2.77B
$2.25M 1.23%
104,380
-92,569
CORT icon
12
Corcept Therapeutics
CORT
$7.74B
$571K 0.31%
+5,000
IMCR icon
13
Immunocore
IMCR
$1.67B
$267K 0.15%
+9,011
RAPT icon
14
RAPT Therapeutics
RAPT
$751M
$134K 0.07%
+13,729
AXSM icon
15
Axsome Therapeutics
AXSM
$6.74B
– –
-174,769
CYTK icon
16
Cytokinetics
CYTK
$7.61B
– –
-20,000
PHAT icon
17
Phathom Pharmaceuticals
PHAT
$964M
– –
-2,274,157
PLRX icon
18
Pliant Therapeutics
PLRX
$103M
– –
-535,494
TRVI icon
19
Trevi Therapeutics
TRVI
$1.42B
– –
-1,084,135
ATYR
20
aTyr Pharma
ATYR
$84.9M
– –
-432,561
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.84B
– –
-1,004,790